• citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:1
  • full-text downloads in 30 days:1


article: 5 from 34  
Back back to result list
2015, vol. 61, iss. 3, pp. 111-119
GMO: Two decades after the first commercialization
aInstitute of Agricultural Economics, Belgrade, Serbia
bUniversity of Novi Sad, Faculty of Economy, Subotica, Serbia,
Keywords: transgenic plants; monopoly; recession
Regarding transgenic plants growth and food derived from genetically modified organisms (GMO) there is a large disagreement about its environmental and health adverse effects as well as about socio-economic implications. In the spirit of the general debate which is not slowing down, in this work we have analyzed some indicators and consequences of the transgenic technology diffusion. Our work showed that biotechnology industry successfully recovered from 2008 recession, even the industry for the first time operated without losses, Also, it has been shown that the economic crisis contributed to the further strengthening of the monopoly power of the biggest companies. Bearing in mind, technological underdevelopment as well as fact that small companies collapsed during the crisis it is clear that Serbia cannot compete with multinationals at the biotech market.
Ernst&Young (2013) Beyond borders, matter of evidence.$FILE/Beyond_borders.pdf, (12.06.2015)
Ernst&Young (2014) Beyond borders, unlocking value.$FILE/EY-beyond-borders-unlocking-value.pdf, (16.04.2015)
Ernst&Young (2009) Beyond borders: Global biotechnology report 2009., (11.12.2014)
FAO (2004) The state of food insecurity in the world 2004: Monitoring progress towards the world food summit and millennium development goals. Rome, Italy
James, C. (2008) Global status of commercialized biotech/GM crops. in: The First Thirteen Years, 1996 to 2008. ISAAA Brief 39-2008, Ithaca
James, C. (2012) Global status of commercialized Biotech/GM crops: 2012. in: ISAAA Brief No. 44, Ithaca, NY: ISAAA
James, C. (2014) Global status of commercialized Biotech/GM crops: 2014. in: ISAAA Brief No. 49, Ithaca, NY: ISAAA
Papic, B. (2013) Hrana buducnosti ili bioterorizam. Beograd: Sluzbeni glasnik
Papic, B.T. (2013) Serbia as a country free of transgenic production: States and challenges. in: Cvijanović D., Subić J., Vasile A.J. [ed.] Sustainable agriculture and rural development in terms of the republic of Serbia strategic goals realization within the Danube region- achieving regional competitiveness, Belgrade: Institute of Agricultural Economics, pp. 1511-1527
Papić, B.T., Lovre, K. (2013) Genetically modified food: An overview. in: Radović Marković M., Vojteski Kljanak D., Jovančević D. [ed.] Employment, Education and Entrepreneurship, Belgrade: Faculty of Business Economics and Entrepreneurship, pp. 283-303
Papić, T., Lovre, K. (2008) Politika multinacionalnih kompanija u proizvodnji genetski modifikovanih biljnih kultura. Ekonomika poljoprivrede, vol. 55, br. 4, str. 389-396
Papić-Brankov, T., Lovre, K. (2010) Implikacije svetske ekonomske krize na biotehnološku industriju. Ekonomika poljoprivrede, vol. 57, br. 3, str. 369-376
Papić-Brankov, T., Lovre, K. (2011) Investment research and development in agricultural biotechnology. Ekonomika, vol. 57, br. 1, str. 30-36
van Berkum, S., Bogdanov, N. (2012) Serbia on the road to EU accession: Consequences for agricultural policy and the agri-food chain. UK: CABI


article language: English
document type: Review Paper
DOI: 10.5937/ekonomika1503111P
published in SCIndeks: 25/10/2015

Related records

No related records